Literature DB >> 15277049

Taste function in elderly patients with unilateral middle ear disease.

Tomonori Terada1, Mieko Sone, Kojiro Tsuji, Yasuo Mishiro, Masafumi Sakagami.   

Abstract

OBJECTIVE: It is generally said that taste function deteriorates naturally with age. Taste function after middle ear surgery in elderly patients has not been clarified.
MATERIAL AND METHODS: The taste function of the chorda tympani nerve on the normal and diseased sides was examined before and after middle ear surgery using electrogustometry in 79 patients aged>60 years, and the findings were compared with those in 228 young and middle-aged patients.
RESULTS: The threshold of electrogustometry on the normal side increased significantly with increasing age (p<0.0001). The rate of thresholds that were off the scale was highest in the>70 years age group. The preoperative threshold on the diseased side increased significantly with increasing age in patients with chronic otitis media (p=0.0029) and cholesteatoma (p<0.0001). In patients with chronic otitis media, the postoperative threshold of the>60 years age group tended to be higher than that of the<60 years age group.
CONCLUSIONS: These findings suggest that the taste function of the chorda tympani nerve deteriorated on the diseased side as much as on the normal side in elderly patients. Therefore, in most cases, we do not have to pay as much attention to the chorda tymapani nerve when performing surgery in elderly patients compared to young and middle-aged patients.

Entities:  

Mesh:

Year:  2004        PMID: 15277049     DOI: 10.1080/03655230410017797

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  2 in total

Review 1.  Relationship between pediatric obesity and otitis media with effusion.

Authors:  Sun Kyu Lee; Seung Geun Yeo
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

Review 2.  Oral sensory nerve damage: Causes and consequences.

Authors:  Derek J Snyder; Linda M Bartoshuk
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.